Platomics Revenue and Competitors
Estimated Revenue & Valuation
- Platomics's estimated annual revenue is currently $14.2M per year.
- Platomics's estimated revenue per employee is $145,000
Employee Data
- Platomics has 98 Employees.
- Platomics grew their employee count by 66% last year.
Platomics's People
Name | Title | Email/Phone |
---|
Platomics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.7M | 59 | 40% | N/A | N/A |
#2 | $27.4M | 172 | 6% | N/A | N/A |
#3 | $8.1M | 62 | 5% | N/A | N/A |
#4 | $23.1M | 145 | 28% | N/A | N/A |
#5 | $5.1M | 44 | 38% | N/A | N/A |
#6 | $9.4M | 72 | 6% | N/A | N/A |
#7 | $4.2M | 36 | 9% | N/A | N/A |
#8 | $5.1M | 44 | 5% | N/A | N/A |
#9 | $8.7M | 67 | 5% | N/A | N/A |
#10 | $13.5M | 93 | -7% | N/A | N/A |
What Is Platomics?
Personalized medicine allows increasingly deeper insights into the human organism with the aim to achieve a more effective treatment for patients according to their individual physical characteristics. A first step in this direction personalized medicine already applies to genetic diseases: using Next Generation Sequencing (NGS), thousands of mutations in the human genome can be analyzed in parallel. This information allows the physician to make the right decision for further treatment. In this scenario, Platomics sees itself as an infrastructure provider for the digitization of workflows between physicians, laboratory and test provider, using the most modern methods of information technology and artificial intelligence. Our digital infrastructure, PlatoX™, plays a key role in providing high analysis quality, highly scalable testing procedures, and above all the highest protection of patient data safety.
keywords:N/AN/A
Total Funding
98
Number of Employees
$14.2M
Revenue (est)
66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 98 | 58% | N/A |
#2 | $15.2M | 98 | 9% | $12.9M |
#3 | $11.8M | 98 | -2% | N/A |
#4 | N/A | 99 | 5% | N/A |
#5 | $21.8M | 99 | 8% | N/A |